South San Francisco-based company Human Longevity, Inc. revealed on May 11, 2026, that they have introduced a new Clinical-Grade Whole Genome Sequencing Report priced at $599. This report aims to make cutting-edge genomic medicine and AI-powered disease prevention more accessible to the public. The initiative marks a significant step in enhancing healthcare services for individuals by offering comprehensive genetic insights at an affordable price point.